S

S2Medical AB (publ)
STO:S2M

Watchlist Manager
S2Medical AB (publ)
STO:S2M
Watchlist
Price: 0.0149 SEK 2.05%
Market Cap: 12.5m SEK

Relative Value

The Relative Value of one S2M stock under the Base Case scenario is 0.0305 SEK. Compared to the current market price of 0.0149 SEK, S2Medical AB (publ) is Undervalued by 51%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

S2M Relative Value
Base Case
0.0305 SEK
Undervaluation 51%
Relative Value
Price
S
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
85
vs Industry
70
Median 3Y
1.7
Median 5Y
1.7
Industry
2.3
vs History
3
vs Industry
Median 3Y
-0.8
Median 5Y
-1.1
Industry
22
vs History
vs Industry
56
Median 3Y
-0.8
Median 5Y
-1.3
Industry
14.3
vs History
vs Industry
Median 3Y
-0.9
Median 5Y
-1.2
Industry
20
vs History
76
vs Industry
68
Median 3Y
1.4
Median 5Y
1.3
Industry
2.2
vs History
74
vs Industry
75
Median 3Y
1
Median 5Y
1
Industry
2.4
vs History
76
vs Industry
83
Median 3Y
1
Median 5Y
1.8
Industry
5
vs History
7
vs Industry
54
Median 3Y
-0.3
Median 5Y
-0.8
Industry
11.6
vs History
9
vs Industry
49
Median 3Y
-0.2
Median 5Y
-0.7
Industry
15.9
vs History
vs Industry
57
Median 3Y
-0.7
Median 5Y
-0.9
Industry
14.3
vs History
vs Industry
46
Median 3Y
-0.7
Median 5Y
-0.8
Industry
18
vs History
63
vs Industry
78
Median 3Y
0.6
Median 5Y
0.9
Industry
1.8

Multiples Across Competitors

S2M Competitors Multiples
S2Medical AB (publ) Competitors

Market Cap P/S P/E EV/EBITDA EV/EBIT
SE
S2Medical AB (publ)
STO:S2M
12.6m SEK 0.8 2.2 1.7 2
CH
Alcon AG
SIX:ALC
34.9B CHF 4.4 38.9 17.9 33.8
JP
Hoya Corp
TSE:7741
6.3T JPY 7.3 31.2 19.2 23
DK
Coloplast A/S
CSE:COLO B
136.7B DKK 4.9 30.2 17.4 20.5
US
Align Technology Inc
NASDAQ:ALGN
14B USD 3.5 34.3 16.4 20.2
CH
Ypsomed Holding AG
SIX:YPSN
5.9B CHF 7.8 67.2 32.1 54.8
UK
ConvaTec Group PLC
LSE:CTEC
4.9B GBP 2.9 34.9 207.9 340.1
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
42.7B CNY 12.1 30.6 26.3 26.3
US
Lantheus Holdings Inc
NASDAQ:LNTH
5.1B USD 3.3 20 9.2 10.5
KR
HLB Inc
KOSDAQ:028300
7.1T KRW 94.9 -37.6 -66.7 -63.1
CA
Bausch + Lomb Corp
NYSE:BLCO
5B USD 1 -13.8 17.2 75.6
P/E Multiple
Earnings Growth PEG
SE
S
S2Medical AB (publ)
STO:S2M
Average P/E: 32.2
2.2
N/A N/A
CH
Alcon AG
SIX:ALC
38.9
28%
1.4
JP
Hoya Corp
TSE:7741
31.2
N/A N/A
DK
Coloplast A/S
CSE:COLO B
30.2
14%
2.2
US
Align Technology Inc
NASDAQ:ALGN
34.3
30%
1.1
CH
Ypsomed Holding AG
SIX:YPSN
67.2
N/A N/A
UK
ConvaTec Group PLC
LSE:CTEC
34.9
33%
1.1
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
30.6
20%
1.5
US
Lantheus Holdings Inc
NASDAQ:LNTH
20
25%
0.8
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -37.6 N/A N/A
CA
Bausch + Lomb Corp
NYSE:BLCO
Negative Multiple: -13.8 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
SE
S
S2Medical AB (publ)
STO:S2M
Average EV/EBITDA: 36.5
1.7
N/A N/A
CH
Alcon AG
SIX:ALC
17.9
10%
1.8
JP
Hoya Corp
TSE:7741
19.2
9%
2.1
DK
Coloplast A/S
CSE:COLO B
17.4
9%
1.9
US
Align Technology Inc
NASDAQ:ALGN
16.4
15%
1.1
CH
Ypsomed Holding AG
SIX:YPSN
32.1
N/A N/A
UK
ConvaTec Group PLC
LSE:CTEC
207.9
11%
18.9
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
26.3
18%
1.5
US
Lantheus Holdings Inc
NASDAQ:LNTH
9.2
21%
0.4
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -66.7 N/A N/A
CA
Bausch + Lomb Corp
NYSE:BLCO
17.2
19%
0.9
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
SE
S
S2Medical AB (publ)
STO:S2M
Average EV/EBIT: 60.7
2
N/A N/A
CH
Alcon AG
SIX:ALC
33.8
25%
1.4
JP
Hoya Corp
TSE:7741
23
N/A N/A
DK
Coloplast A/S
CSE:COLO B
20.5
9%
2.3
US
Align Technology Inc
NASDAQ:ALGN
20.2
17%
1.2
CH
Ypsomed Holding AG
SIX:YPSN
54.8
N/A N/A
UK
ConvaTec Group PLC
LSE:CTEC
340.1
22%
15.5
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
26.3
16%
1.6
US
Lantheus Holdings Inc
NASDAQ:LNTH
10.5
22%
0.5
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -63.1 N/A N/A
CA
Bausch + Lomb Corp
NYSE:BLCO
75.6
55%
1.4